176 related articles for article (PubMed ID: 32781053)
21. Podocytes, signaling pathways, and vascular factors in diabetic kidney disease.
Brosius FC; Coward RJ
Adv Chronic Kidney Dis; 2014 May; 21(3):304-10. PubMed ID: 24780459
[TBL] [Abstract][Full Text] [Related]
22. Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy.
Liu N; Xu L; Shi Y; Zhuang S
J Diabetes Res; 2017; 2017():3560238. PubMed ID: 28512641
[TBL] [Abstract][Full Text] [Related]
23. Failure to phosphorylate AKT in podocytes from mice with early diabetic nephropathy promotes cell death.
Tejada T; Catanuto P; Ijaz A; Santos JV; Xia X; Sanchez P; Sanabria N; Lenz O; Elliot SJ; Fornoni A
Kidney Int; 2008 Jun; 73(12):1385-93. PubMed ID: 18385666
[TBL] [Abstract][Full Text] [Related]
24. Signaling in regulation of podocyte phenotypes.
Chuang PY; He JC
Nephron Physiol; 2009; 111(2):p9-15. PubMed ID: 19142027
[TBL] [Abstract][Full Text] [Related]
25. The Role of PKGIα and AMPK Signaling Interplay in the Regulation of Albumin Permeability in Cultured Rat Podocytes.
Rachubik P; Rogacka D; Audzeyenka I; Szrejder M; Topolewska A; Rychłowski M; Piwkowska A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835364
[TBL] [Abstract][Full Text] [Related]
26. An In Vitro Method to Analyze Glucose Uptake in Podocytes.
Lay AC; Coward RJ
Methods Mol Biol; 2020; 2067():139-143. PubMed ID: 31701450
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway.
Zhang Y; Chen X; Yuan L; Zhang Y; Wu J; Guo N; Chen X; Liu J
Biochem Biophys Res Commun; 2018 Nov; 506(3):529-535. PubMed ID: 30361091
[TBL] [Abstract][Full Text] [Related]
28. Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice.
Kang MK; Park SH; Kim YH; Lee EJ; Antika LD; Kim DY; Choi YJ; Kang YH
Acta Pharmacol Sin; 2017 Aug; 38(8):1129-1140. PubMed ID: 28502979
[TBL] [Abstract][Full Text] [Related]
29. Glycyrrhizic Acid Protects Glomerular Podocytes Induced by High Glucose by Modulating SNARK/AMPK Signaling Pathway.
Zhao TQ; Li Y; Zhang M; Zhao MC; Cao X; Hou SZ
Curr Med Sci; 2023 Aug; 43(4):696-707. PubMed ID: 37450070
[TBL] [Abstract][Full Text] [Related]
30. APPL1 acts as a protective factor against podocytes injury in high glucose environment.
Ji Z; Hu Z; Xu Y
Int J Clin Exp Pathol; 2015; 8(6):6764-71. PubMed ID: 26261560
[TBL] [Abstract][Full Text] [Related]
31. AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.
Eid AA; Ford BM; Block K; Kasinath BS; Gorin Y; Ghosh-Choudhury G; Barnes JL; Abboud HE
J Biol Chem; 2010 Nov; 285(48):37503-12. PubMed ID: 20861022
[TBL] [Abstract][Full Text] [Related]
32. 5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway.
Gao K; Chi Y; Sun W; Takeda M; Yao J
Mol Pharmacol; 2014 Mar; 85(3):460-71. PubMed ID: 24378334
[TBL] [Abstract][Full Text] [Related]
33. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
[TBL] [Abstract][Full Text] [Related]
34. Eucalyptol Inhibits Advanced Glycation End Products-Induced Disruption of Podocyte Slit Junctions by Suppressing Rage-Erk-C-Myc Signaling Pathway.
Kim DY; Kang MK; Lee EJ; Kim YH; Oh H; Kang YH
Mol Nutr Food Res; 2018 Oct; 62(19):e1800302. PubMed ID: 29987888
[TBL] [Abstract][Full Text] [Related]
35. Insulin increases glomerular filtration barrier permeability through PKGIα-dependent mobilization of BKCa channels in cultured rat podocytes.
Piwkowska A; Rogacka D; Audzeyenka I; Kasztan M; Angielski S; Jankowski M
Biochim Biophys Acta; 2015 Aug; 1852(8):1599-609. PubMed ID: 25952906
[TBL] [Abstract][Full Text] [Related]
36. Podocyte biology in diabetic nephropathy.
Li JJ; Kwak SJ; Jung DS; Kim JJ; Yoo TH; Ryu DR; Han SH; Choi HY; Lee JE; Moon SJ; Kim DK; Han DS; Kang SW
Kidney Int Suppl; 2007 Aug; (106):S36-42. PubMed ID: 17653209
[TBL] [Abstract][Full Text] [Related]
37. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.
Langer S; Kreutz R; Eisenreich A
J Nephrol; 2016 Dec; 29(6):765-773. PubMed ID: 26733332
[TBL] [Abstract][Full Text] [Related]
38. CTRP4 attenuates apoptosis and epithelial-mesenchymal transition markers in podocytes through an AMPK/autophagy-dependent pathway.
Cho W; Oh H; Choi SW; Abd El-Aty AM; Birdal O; Jeong JH; Song JH; Jung TW
Biochem Biophys Res Commun; 2023 Nov; 682():104-110. PubMed ID: 37806247
[TBL] [Abstract][Full Text] [Related]
39. Podocyte Lysosome Dysfunction in Chronic Glomerular Diseases.
Li G; Kidd J; Li PL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32106480
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
